Health In Tech, Inc. Class A Common Stock logo

Health In Tech, Inc. Class A Common Stock(HIT)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL
1-STAR RATING
PASS
LAST CLOSE
$0.4
11/13/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for HIT

11/13/2026: HIT (1-star) is currently NOT-A-BUY. Pass it for now.

Health In Tech is a micro-cap InsurTech platform company that provides AI-enabled software and underwriting solutions to streamline self-funded health insurance for employers. The company's main business strengths include its proprietary eDIYBS quoting software and vertically integrated managing general underwriter capabilities. Its primary growth opportunity lies in capturing market share within the large U.S. self-funded health benefits sector through expanded broker distribution. However, the investment story carries notable risks, including recent revenue adjustments from carrier delays, ongoing net losses, and high stock price volatility. The stock may best suit speculative growth investors willing to monitor pipeline conversion rates and leadership execution under CEO Sanjay Shrestha.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorMixed fitWhile operating in the expanding InsurTech sector, recent revenue revisions and near-term losses temper its immediate growth appeal.
Momentum investorWeak fitTreat Momentum fit as conditional on a positive Upturn signal (Strong Buy / Buy); the stock currently trades near multi-month lows.
Value investorMixed fitThe micro-cap valuation is low on a price-to-sales basis, but ongoing net losses make fundamental value assessment challenging.
Dividend investorWeak fitThe company does not pay dividends, rendering it entirely unsuitable for income-focused strategies.
Low-risk investorWeak fitHigh share price volatility and micro-cap liquidity risks expose conservative investors to substantial capital loss.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityHighMicro-cap status and low liquidity contribute to sharp intraday and multi-week price swings.
Valuation riskMedium / highUncertainty regarding future profitability makes earnings-based valuation metrics negative or unstable.
Competition risk (InsurTech and software competition)Medium / highThe company must continuously innovate to protect its niche against well-funded software and insurance incumbents.
Business qualityMediumProprietary SaaS and MGU integration offer differentiation, but scale is still nascent.
Dividend incomeLow / noneNo dividend is paid or anticipated as capital is reinvested into operations.
Execution riskHighNew leadership under CEO Sanjay Shrestha must successfully convert pipeline opportunities and resolve carrier delays.

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 25.83M USD
Price to earnings Ratio -
1Y Target Price 2.37
Price to earnings Ratio -
1Y Target Price 2.37
Volume (30-day avg) 70.5K shares
Beta -
52 Weeks Range 0.36 - 2.10
Updated Date 11/15/2026
52 Weeks Range 0.36 - 2.10
Updated Date 11/15/2026
Dividends yield (FY) -
Basic EPS (TTM) -0.07

Sector & Industry Intelligence

Sector

Technology

Caution
Sentiment
Near Bearish
Momentum
Rapid Breadth Deterioration
BUY participation
30.1%
Active BUY / eligible
37 / 123
30-Day BUY Count Change
-42
Market state
Weak Bullish / Near Bearish

BUY participation is falling rapidly, suggesting elevated market vulnerability.

Industry

Software - Application

BUY participation
55.0%
Active BUY / eligible
11 / 20
30-Day BUY Count Change
-1

Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.

Price Behavior

Steep Decline
PRICE PATH

Steep Decline

The stock price has dropped sharply with strong downward pressure.

Highly Choppy
PRICE STABILITY

Highly Choppy

The stock has experienced frequent, large price swings that make its near-term movement less predictable.

Analysis of Past Performance

Type Stock
Historic Profit -50.86%
Avg. Invested days 21
Today’s Advisory PASS
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 3.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/13/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
HIT receives a 3-star rating, supported by solid analyst coverage. The rating is constrained by soft unit economics, and weak price momentum.

Company Fundamentals

★★★★★
HIT has moderate overall fundamentals (3 stars), with moderate financial health, solid growth momentum, and moderate ownership. In FY2025 versus FY2024, strong earnings growth (+90.7%) and strong revenue growth (+71.0%) are partially offset by weak cash generation (FCF margin -0.2%), soft profitability (net margin 3.8%).

Financial Health Rating

★★★★★
HIT's financial health is supported by solid liquidity, including working-capital and asset support (WC/assets 47.7%). Profitability is moderate (3 stars), which helps explain the 3-star overall score.

Growth Momentum Score

★★★★★
Earnings growth is HIT's strongest growth driver at +90.7% FY2025 versus FY2024 (strong, 5 stars). By comparison, revenue growth (+71.0%, strong) is also strong, while free-cash-flow growth (-104.4%, negative) holds the profile back, so recent growth is not broad-based across the business.

Ownership

★★★★★
Institutional ownership is 9.3% (soft) and 22.5% of outstanding shares are publicly tradable (soft). Insider ownership of 77.00% supports management-shareholder alignment.

Top 5 Institutional Investors

Whetstone Capital Advisors, LLC 2.31%
Mink Brook Asset Management LLC 1.74%
Vanguard Capital Management, LLC 0.87%
Heights Capital Management Inc 0.54%
BlackRock Inc 0.54%

Unit Economics (Per $1K Revenue)

★★★★★
HIT generates approximately $628 of gross profit, $46 of operating income, and $-2 of free cash flow for every $1,000 of revenue. Based on FY2025 results. Negative free cash flow explains the 2-star rating, with weak cash conversion and solid capital efficiency.

Economic Dimensions

★★★★★
Effective Tax Rate: 23.61%

Quantitative Style Profile

★★★★★
HIT has a relatively low-volatility profile. Weak momentum is the primary drawback, while valuation that is moderately attractive rather than deeply discounted.

Style Classification

Quality Focused

Low VolatilitySmall / Mid Cap Risk

How Company Makes Money

Business areaWhat it includesRetail investor read
SaaS Platform & Software FeesSubscription and licensing revenue derived from tools like eDIYBS and HitRix used by brokers and employers.The company earns recurring technology fees when insurance professionals use its software to build health plans.
Underwriting & Program ManagementMGU fees, underwriting margins, and administrative services generated through subsidiaries like Stone Mountain Risk.It acts as an administrator and underwriter for self-funded insurance risk, capturing fee-based income.

Valuation

Trailing PE -
Forward PE 8.8
Enterprise Value 19.17M
Price to Sales(TTM) 0.79
Enterprise Value 19.17M
Price to Sales(TTM) 0.79
Enterprise Value to Revenue 0.58
Enterprise Value to EBITDA 291.33
Shares Outstanding 53.60M
Shares Floating 12.04M
Shares Outstanding 53.60M
Shares Floating 12.04M
Percent Insiders 77
Percent Institutions 9.33

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.